Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic refractory ITP in children: beyond splenectomy.

Nicole Sevier1, Mary Houston

  • 1Baylor College of Medicine, Texas Children's Cancer Center and Hematology Service, 6701 Fannin, suite 1400, MC 3-3320, Houston, TX 77030, USA. nmsevier@texaschildrenshospital.org

Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|April 28, 2005
PubMed
Summary

Treatment options for chronic refractory immune thrombocytopenic purpura (ITP) in children remain debated. This review examines current therapies, their risks and benefits, remission rates, and future research directions for this challenging hematologic condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of social determinants of health using multi-label classification of electronic health record clinical notes.

JAMIA open·2021
Same author

Inherited coagulation factor abnormalities: a pediatric review.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses·2005
Same author

Solid tumors in children.

Journal of pediatric nursing·2003
See all related articles

Area of Science:

  • Hematology
  • Pediatric Hematology
  • Immunology

Background:

  • Idiopathic (or immune) thrombocytopenic purpura (ITP) is a common hematologic disorder.
  • Lack of consensus exists regarding optimal treatment strategies for ITP, particularly in chronic refractory cases.
  • Refractory ITP in children presents unique challenges within the broader ITP patient population.

Purpose of the Study:

  • To review available treatment options for pediatric chronic refractory ITP.
  • To analyze the benefits, risks, and remission rates associated with various ITP therapies.
  • To identify areas for ongoing and future research in managing refractory ITP in children.

Main Methods:

  • Literature review of existing treatment modalities for chronic refractory ITP in pediatric patients.

Related Experiment Videos

  • Analysis of clinical trial data and case reports.
  • Synthesis of information on efficacy, safety profiles, and remission rates.

    • Main Results:

    • Current treatment landscape for refractory ITP in children includes immunosuppressants, splenectomy, and novel agents.
    • Variability in treatment response and significant side effect profiles noted across different therapeutic approaches.
    • Limited high-quality evidence exists for many treatment options, highlighting the need for further investigation.

    Conclusions:

    • Management of chronic refractory ITP in children requires individualized treatment strategies.
    • Further research is crucial to establish evidence-based guidelines and optimize outcomes.
    • Future research should focus on novel therapies and predictive markers for treatment response.